| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 24.30B | 21.92B | 24.38B | 23.86B | 23.95B | 23.22B |
| Gross Profit | 8.72B | 7.65B | 8.68B | 7.16B | 9.07B | 9.82B |
| EBITDA | 2.99B | 2.34B | 2.86B | 1.70B | 3.01B | 4.17B |
| Net Income | 1.58B | 1.09B | 1.51B | 603.18M | 1.44B | 2.05B |
Balance Sheet | ||||||
| Total Assets | 20.71B | 21.33B | 21.43B | 22.95B | 21.42B | 20.96B |
| Cash, Cash Equivalents and Short-Term Investments | 12.59B | 12.84B | 12.83B | 13.84B | 13.20B | 12.94B |
| Total Debt | 5.57M | 4.93M | 6.66M | 9.91M | 13.99M | 8.68M |
| Total Liabilities | 6.97B | 7.20B | 7.19B | 8.73B | 6.67B | 6.22B |
| Stockholders Equity | 13.74B | 14.13B | 14.24B | 14.22B | 14.74B | 14.75B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 1.56B | 987.74M | 1.96B | 1.63B | 2.36B |
| Operating Cash Flow | 0.00 | 1.75B | 1.21B | 2.29B | 2.22B | 3.25B |
| Investing Cash Flow | 0.00 | -394.88M | -267.84M | -764.20M | -581.21M | -876.90M |
| Financing Cash Flow | 0.00 | -1.46B | -1.46B | -1.46B | -1.46B | -1.50B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
78 Outperform | ¥33.23B | 11.71 | ― | 3.40% | 8.54% | 20.52% | |
74 Outperform | ¥74.52B | 14.55 | 17.96% | 1.83% | 10.56% | 27.45% | |
71 Outperform | ¥20.70B | 11.94 | ― | 1.70% | 15.21% | 12.50% | |
65 Neutral | ¥34.68B | 31.92 | ― | 3.99% | -10.11% | -27.86% | |
65 Neutral | ¥30.43B | 8.58 | 10.34% | 4.82% | -2.76% | 36.33% | |
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% | |
61 Neutral | ¥5.69B | 13.99 | ― | 1.23% | 12.32% | -14.81% |